Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,651
Total Claims
$928K
Drug Cost
472
Beneficiaries
$1,966
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+84%
Cost per patient vs peers
$1,966 vs $1,068 avg
+117%
Brand preference vs peers
19.5% vs 9.0% avg
Brand vs Generic
Brand: 2,259 claims · $657K
Generic: 9,317 claims · $266K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 396 | $116K |
| Rifaximin | 33 | $73K |
| Insulin Glargine,hum.Rec.Anlog | 310 | $51K |
| Rivaroxaban | 158 | $45K |
| Dulaglutide | 52 | $38K |
| Insulin Aspart | 140 | $27K |
| Empagliflozin | 62 | $19K |
| Insulin Lispro | 108 | $16K |
| Tiotropium Bromide | 34 | $14K |
| Umeclidinium Bromide | 24 | $9,295 |
| Atorvastatin Calcium | 446 | $7,573 |
| Midodrine Hcl | 71 | $7,497 |
| Duloxetine Hcl | 137 | $7,422 |
| Aripiprazole | 62 | $7,410 |
| Potassium Chloride | 281 | $7,330 |
Prescribing Profile
Patient Profile
75
Avg Age
56%
Female
2.91
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data